300 Saginaw Drive
18 articles with SentreHEART, Inc.
AtriCure, Inc. announced that it has entered into a definitive agreement to acquire SentreHEART, Inc., a privately held developer of percutaneous left atrial appendage management solutions.
SentreHEART Announces Initial Clinical Use of the LARIAT® with EpiRAIL™ Procedure for Left Atrial Appendage Exclusion
SentreHEART, Inc., announced it has successfully completed nine First-In-Human procedures utilizing the LARIAT® with EpiRAIL™ at John Paul II hospital in Krakow, Poland.
SentreHEART, Inc. announced its participation and scheduled presentations at the Heart Rhythm Society’s 40th Annual Heart Rhythm Scientific Sessions, in San Francisco, CA on May 8-11, 2019.
SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion
SentreHEART, Inc., announced it has received CE Mark for the LARIAT-RS™ 50mm as well as expanded labeling for the LARIAT-RS for left atrial appendage (LAA) exclusion.
SentreHEART, Inc. announces enrollment of the 400th patient in the prospective, multi-center, randomized controlled Trial known as the aMAZE Trial.
SentreHEART Announces Participation at The American College of Cardiology’s 67th Annual Scientific Session & Expo
SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American College of Cardiology (ACC) 2018 meeting being held in Orlando, Florida, March 10-12, 2018.
SentreHEART will be participating in the 23rd Annual International AF Symposium being held in Orlando, FL, January 11 - 13, 2018.
SentreHEART, the manufacturer of the LARIAT Suture Delivery Device (LARIAT) will be participating in the American Heart Association (AHA) Scientific Sessions 2017 in Anaheim, California November 11-15, 2017.
SentreHEART Amaze Trial Receives FDA Approval For Stage II Expansion Based On 100 Subject Interim Safety And Performance Analysis
SentreHEART To Present On First Of Its Kind Treatment For Atrial Fibrillation At LAA Conference In Frankfurt, Germany
SentreHEART Receives CE Mark Approval For The LARIAT Surgical Left Atrial Appendage Suture Delivery Device